9 Meters Biopharma, Inc. NMTRQ
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -8.39% | -19.00% | -28.60% | -- | -- |
| Total Depreciation and Amortization | 2.50% | 13.33% | 43.55% | -- | -- |
| Total Amortization of Deferred Charges | -- | 4,062.95% | 37.17% | -- | -- |
| Total Other Non-Cash Items | -13.80% | -19.83% | -9.85% | -- | -- |
| Change in Net Operating Assets | -53.21% | -70.38% | 277.81% | -- | -- |
| Cash from Operations | -12.86% | -26.34% | -27.03% | -- | -- |
| Capital Expenditure | 100.00% | 77.60% | 45.45% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | 100.00% | 99.88% | 99.78% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -86.51% | -- | -98.26% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 43.95% | 62.49% | 79.60% | -- | -- |
| Cash from Financing | -77.69% | -51.49% | -70.26% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,261.92% | -289.61% | -134.52% | -- | -- |